News

A total of 408 participants with severe chronic rhinosinusitis and nasal polyps, from ten different countries, were involved ...
GlaxoSmithKline is eyeing another indication for its Nucala (mepolizumab) biologic drug after a phase 3 trial in inflammation caused by nasal polyps hit ... which has a different mechanism of ...
Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.
TUESDAY, May 6, 2025 (HealthDay News) -- For patients with chronic sinusitis and nasal polyps, nasal endoscopic surgery can .
Sanofi and Regeneron’s Dupixent has had the US market for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP ... which has a different mechanism of action targeting IL-4 and ...